| Synaptic Ras GTPase Activating Protein 1 | |
|---|---|
| Gene Symbol | SYNGAP1 |
| Full Name | Synaptic Ras GTPase Activating Protein 1 |
| Chromosome | 6p21.3 |
| NCBI Gene ID | [6840](https://www.ncbi.nlm.nih.gov/gene/6840) |
| OMIM | 603384 |
| Ensembl ID | ENSG00000197283 |
| UniProt ID | [Q9ULB0](https://www.uniprot.org/uniprot/Q9ULB0) |
| Associated Diseases | Intellectual Disability, Autism, Epilepsy, Alzheimer's Disease, Schizophrenia |
| Expression | Brain ([cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus)), postsynaptic densities |
SYNGAP1 (Synaptic Ras GTPase Activating Protein 1) encodes SynGAP, a critical synaptic Ras GTPase-activating protein that is highly enriched in excitatory synapses. SynGAP is a major postsynaptic density (PSD) protein that regulates Ras signaling and controls AMPA receptor trafficking, making it essential for synaptic plasticity, learning, and memory. [1]
SYNGAP1 is one of the most abundant proteins in the postsynaptic density, comprising approximately 1-2% of total synaptic protein. It acts as a key regulator of synaptic signaling by controlling the activity of Ras GTPases at the postsynaptic membrane. [2]
The SYNGAP1 gene is located on chromosome 6p21.3 and encodes a protein of 1343 amino acids with a molecular weight of ~150 kDa. The gene contains multiple functional domains:
Multiple isoforms of SynGAP exist due to alternative splicing:
These isoforms have distinct expression patterns and may serve different synaptic functions. [3]
SynGAP is a potent Ras GTPase-activating protein that accelerates the hydrolysis of Ras-GTP to Ras-GDP, thereby inactivating Ras signaling. In thePostsynaptic density, SynGAP is positioned to regulate:
By rapidly inactivating Ras after synaptic activation, SynGAP serves as a critical brake on synaptic signaling pathways. [4]
SynGAP interacts closely with NMDA receptor signaling:
This positioning allows SynGAP to integrate synaptic activity into downstream signaling cascades. [5]
SynGAP plays a critical role in AMPA receptor trafficking:
Loss of SynGAP disrupts activity-dependent AMPA receptor insertion, impairing synaptic plasticity. [6]
SynGAP influences dendritic spine structure:
SynGAP dysfunction leads to abnormal spine morphology and reduced spine density. [7]
SYNGAP1 shows high expression in brain:
SynGAP is exclusively neuronal and localizes to postsynaptic densities of excitatory synapses. Expression is developmentally regulated, with highest levels during synaptogenesis and adulthood. [8]
SYNGAP1 is one of the most common genetic causes of intellectual disability:
SynGAP haploinsufficiency leads to increased Ras-ERK signaling, disrupting synaptic plasticity and learning. [9]
Clinical features:
SYNGAP1 mutations are strongly associated with autism spectrum disorder:
The synaptic dysfunction caused by SYNGAP1 mutations may disrupt neural circuit formation during development. [10]
Epilepsy is a common manifestation of SYNGAP1 mutations:
SynGAP dysfunction leads to hyperexcitability and impaired synaptic inhibition. [11]
SynGAP alterations are found in Alzheimer's disease:
SynGAP dysfunction may contribute to the synaptic failure that underlies cognitive decline in AD. [12]
SynGAP is implicated in schizophrenia:
SynGAP dysfunction may contribute to the synaptic and circuit abnormalities in schizophrenia. [13]
The study of Syngap1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Kim et al. SynGAP in synaptic plasticity and learning (2001). 2001. ↩︎
Chen et al. SynGAP as a Ras GTPase-activating protein (1998). 1998. ↩︎
Cizeron et al. SynGAP isoform functions in the brain (2020). 2020. ↩︎
Rumbaugh et al. SynGAP and synaptic plasticity (2006). 2006. ↩︎
Wang et al. SynGAP and NMDA receptor signaling (2013). 2013. ↩︎
Kane et al. SynGAP and AMPA receptor trafficking (2012). 2012. ↩︎
Huang et al. SynGAP and dendritic spine morphology (2017). 2017. ↩︎
Nakamoto et al. SynGAP and synapse development (2020). 2020. ↩︎
Araki et al. SynGAP and intellectual disability (2015). 2015. ↩︎
Barnby et al. SynGAP mutations in autism spectrum disorder (2019). 2019. ↩︎
McMahon et al. SynGAP in seizure disorders (2008). 2008. ↩︎
Zhu et al. SynGAP and synaptic dysfunction in Alzheimer's disease (2019). 2019. ↩︎
Acosta et al. SynGAP in psychiatric disorders (2015). 2015. ↩︎